Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Regional Delivery Grant

    Regional Delivery Grant supports organizers of oligonucleotide research meetings, funding events that help researchers share knowledge, build regional connections, and access professional development.

    Browse similar grants
    New Research Grants This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Oligonucleotide Therapeutics Society

    Due Dates: Rolling (Applications) | November 15, 2026 (November review) | March 15, 2027 (March review) | October 15, 2027 (Annual review)

    Funding Amounts: $5,000–$50,000 USD; event and spending must be completed within 18 months of funding

    Summary: Supports regional oligonucleotide research meetings that broaden OTS’s reach and provide networking and professional development.

    Key Information: The primary organizer must be a current OTS member, and regional meetings must have at least 100 attendees.


    Description

    The Oligonucleotide Therapeutics Society (OTS) Regional Delivery Grant supports new and established regional meetings and conferences for oligonucleotide researchers. The program funds meeting production rather than individual research projects, helping researchers share knowledge, build regional connections, and access networking and professional development opportunities. Regional outreach guidance emphasizes multi-day meetings that include students and junior researchers and help build oligonucleotide research communities around the world.

    Alongside financial support, recipients receive a listing on the OTS events calendar and assistance from an OTS mentor. OTS can support outreach, speaker recruitment, and fundraising, including help from its Board of Directors in recruiting oligonucleotide experts. Organizers must maintain their own infrastructure for planning and managing the event.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.